Exhibit 99

 

JOINT FILER INFORMATION

 

Joint Filer Name:

 

Polaris Venture Partners III, L.P.

Relationship to Issuer:

 

10% Owner

Address:

 

1000 Winter Street, Suite 3350

Waltham, MA 02451

Designated Filer:

 

Polaris Venture Management Co. III, L.L.C.

Date of Event Requiring Statement:

 

12/10/04

Issuer Name and Ticker or Trading Symbol:

 

Alnylam Pharmaceuticals Inc. (ALNY)

 

 

 

Signature

 

Polaris Venture Partners III, L.P.

 

 

By:

Polaris Venture Management Co. III L.L.C.

Its General Partner

 

 

 

 

 

By:

/s/ Kevin Littlejohn

 

 

 

Kevin Littlejohn, Authorized Signatory

 

 

 

Joint Filer Name:

 

Polaris Venture Partners Entrepreneurs’ Fund III, L.P

Relationship to Issuer:

 

10% Owner

Address:

 

1000 Winter Street, Suite 3350

Waltham, MA 02451

Designated Filer:

 

Polaris Venture Management Co. III, L.L.C.

Date of Event Requiring Statement:

 

12/10/04

Issuer Name and Ticker or Trading Symbol:

 

Alnylam Pharmaceuticals Inc. (ALNY)

 

 

 

Signature

 

Polaris Venture Partners Entrepreneurs’ Fund III, L.P.

 

 

By:

Polaris Venture Management Co. III L.L.C.

Its General Partner

 

 

 

 

 

 

By:

/s/ Kevin Littlejohn

 

 

 

Kevin Littlejohn, Authorized Signatory

 

 

 

Joint Filer Name:

 

Polaris Venture Partners Founders’ Fund III, L.P

Relationship to Issuer:

 

10% Owner

Address:

 

1000 Winter Street, Suite 3350

Waltham, MA 02451

Designated Filer:

 

Polaris Venture Management Co. III, L.L.C.

Date of Event Requiring Statement:

 

12/10/04

Issuer Name and Ticker or Trading Symbol:

 

Alnylam Pharmaceuticals Inc. (ALNY)

 

 

 

Signature

 

Polaris Venture Partners Founders’ Fund III, L.P.

 

 

By:

Polaris Venture Management Co. III L.L.C.

Its General Partner

 

 

 

 

 

 

By:

/s/ Kevin Littlejohn

 

 

 

Kevin Littlejohn, Authorized Signatory

 

 

 

 


 

Joint Filer Name:

 

North Star Venture Management 2000, L.L.C.

Relationship to Issuer:

 

10% Owner, as provider of investment advisory services to PVM III, the general partner of PVP III, PVPEF III and PVPFF III (the reporting person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein)

Address:

 

1000 Winter Street, Suite 3350

Waltham, MA 02451

Designated Filer:

 

Polaris Venture Management Co. III, L.L.C.

Date of Event Requiring Statement:

 

12/10/04

Issuer Name and Ticker or Trading Symbol:

 

Alnylam Pharmaceuticals Inc. (ALNY)

 

 

 

Signature

 

North Star Venture Management 2000, L.L.C.

 

 

 

 

 

By:

/s/ Kevin Littlejohn

 

 

 

Kevin Littlejohn, Authorized Signatory

 

 

 

Joint Filer Name:

 

Stephen D. Arnold

Relationship to Issuer:

 

10% Owner, as managing member of PVM III, the general partner of PVP III, PVPEF III and PVPFF III (the reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein)

Address:

 

1000 Winter Street, Suite 3350

Waltham, MA 02451

Designated Filer:

 

Polaris Venture Management Co. III, L.L.C.

Date of Event Requiring Statement:

 

12/10/04

Issuer Name and Ticker or Trading Symbol:

 

Alnylam Pharmaceuticals Inc. (ALNY)

 

 

 

Signature

 

Stephen D. Arnold

 

 

 

 

 

By:

/s/ Kevin Littlejohn

 

 

 

Kevin Littlejohn, Authorized Signatory

 

 

 

Joint Filer Name:

 

Jonathan A. Flint

Relationship to Issuer:

 

10% Owner, as managing member of PVM III, the general partner of PVP III, PVPEF III and PVPFF III (the reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein)

Address:

 

1000 Winter Street, Suite 3350

Waltham, MA 02451

Designated Filer:

 

Polaris Venture Management Co. III, L.L.C.

Date of Event Requiring Statement:

 

12/10/04

Issuer Name and Ticker or Trading Symbol:

 

Alnylam Pharmaceuticals Inc. (ALNY)

 

 

 

Signature

 

Jonathan A. Flint

 

 

 

 

 

By:

/s/ Kevin Littlejohn

 

 

 

Kevin Littlejohn, Authorized Signatory

 

 

 

 


 

Joint Filer Name:

 

Terrance G. McGuire

Relationship to Issuer:

 

10% Owner, as managing member of PVM III, the general partner of PVP III, PVPEF III and PVPFF III (the reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein)

Address:

 

1000 Winter Street, Suite 3350

Waltham, MA 02451

Designated Filer:

 

Polaris Venture Management Co. III, L.L.C.

Date of Event Requiring Statement:

 

12/10/04

Issuer Name and Ticker or Trading Symbol:

 

Alnylam Pharmaceuticals Inc. (ALNY)

 

 

 

Signature

 

Terrance G. McGuire

 

 

 

 

 

By:

/s/ Kevin Littlejohn

 

 

 

Kevin Littlejohn, Authorized Signatory

 

 

 

Joint Filer Name:

 

Alan G. Spoon

Relationship to Issuer:

 

10% Owner, as managing member of PVM III, the general partner of PVP III, PVPEF III and PVPFF III (the reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein)

Address:

 

1000 Winter Street, Suite 3350

Waltham, MA 02451

Designated Filer:

 

Polaris Venture Management Co. III, L.L.C.

Date of Event Requiring Statement:

 

12/10/04

Issuer Name and Ticker or Trading Symbol:

 

Alnylam Pharmaceuticals Inc. (ALNY)

 

 

 

Signature

 

Alan G. Spoon

 

 

 

 

 

By:

/s/ Kevin Littlejohn

 

 

 

Kevin Littlejohn, Authorized Signatory